You are here: Home » News-CM » Companies » News
Business Standard

Alkem Laboratories intimates of successful USFDA inspection of Bioequivalence facility

Capital Market 

At Taloja

Alkem Laboratories announced that US FDA had conducted an inspection at the Company's Bioequivalence facility located at Taloja, India from 10 July, 2017 to 14 July, 2017. At the end of the inspection, no Form 483 was issued.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

RECOMMENDED FOR YOU